HistologiX is a leading GLP/GCP accredited Contract Research Organisation based in the UK specialising in Histology, Immunohistochemistry (IHC) and Digital Pathology services. HistologiX works with a broad range of clients from big pharma to small and medium biotech companies worldwide. Our team of scientists have in excess of 120 years combined experience and a customer retention rate of 80%.
PPD ® Laboratory services combine high-quality scientific expertise with industry-leading technologies supported by a commitment to exceptional quality to deliver contract laboratory services to the pharmaceutical landscape. Their customers benefit from comprehensive lab services backed by PPD’s more than 30 years’ experience as a contract research organization.
What is it? When you plan to access our technology platform, we will assist you in validating your assay technology in our platform technology. Pending on your needs, we will accept your images, your plates with samples or we will create samples according to your protocols. How to use it? Simply contact us. What do we do? Under CDA, we’ll work out with you with a tailor-made work plan for you to evaluate and order.…
Charles River is a preclinical drug discovery CRO that manages your project from drug target discovery to hit identification, hit-to-lead, and lead optimization
QPS Global Custom-Built Regulatory Services Can Transform Clinical Trials. QPS Global Regulatory Affairs (GRA) service offerings focus on helping pharmaceutical, biotechnology, and medical device companies to develop custom-built research solutions that forge expedited regulatory pathways from discovery to global commercialization and onwards through product lifecycle support.
Moving quickly and safely through Phase I/IIa trials is critical to successful drug development. The QPS Phase I research facilities feature more than 550 beds across six strategically located facilities on three continents. QPS is well known for its success in first-in-human clinical trials. All Phase I sites are staffed by expert clinical pharmacology teams that routinely conduct hundreds of phase I/IIa studies annually.
At QPS, we realize that in today’s late stage drug development space you face many challenges. With our deep experience and broad global presence, QPS is in an excellent position to offer solutions to all of the above needs. With its site management & monitoring teams operating from 30 locations on three continents (Asia/Pacific, USA, and Europe), QPS has become a new strong player in Phase II/IV clinical research services.
